Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore
Authors:
- Antonio GarofaloAGAntonio Garofalo
- Nouri NeamatiNNNouri Neamati
- 1 July 2007
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (14) , 4985-5002
Abstract
No abstract availableKeywords
Funding Information
- Campbell Foundation
This publication has 31 references indexed in Scilit:
- A potent and orally active HIV-1 integrase inhibitorBioorganic & Medicinal Chemistry Letters, 2007
- Design, synthesis, and SAR studies of novel and highly active tri-cyclic HIV integrase inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- A Boronic-Chalcone Derivative Exhibits Potent Anticancer Activity through Inhibition of the ProteasomeMolecular Pharmacology, 2006
- Triketoacid inhibitors of HIV-integrase: A new chemotype useful for probing the integrase pharmacophoreBioorganic & Medicinal Chemistry Letters, 2006
- Anticancer activities of novel chalcone and bis-chalcone derivativesBioorganic & Medicinal Chemistry, 2006
- Novel Bifunctional Quinolonyl Diketo Acid Derivatives as HIV-1 Integrase Inhibitors: Design, Synthesis, Biological Activities, and Mechanism of ActionJournal of Medicinal Chemistry, 2006
- Dynamic Pharmacophore Model Optimization: Identification of Novel HIV-1 Integrase InhibitorsJournal of Medicinal Chemistry, 2006
- Novel HIV-1 Integrase Inhibitors Derived from Quinolone AntibioticsJournal of Medicinal Chemistry, 2006
- A small-molecule antagonist of virion assemblyExpert Opinion on Investigational Drugs, 2001
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997